Study of Health Effects of DDT in Mexico

最近的数据继续表明，使用杀虫剂滴滴涕可能会对人类健康产生不利影响，但基本上没有关于这一主题的发现被重复，因此这个问题仍然悬而未决。滴滴涕是否有不良影响很重要，因为约有12个国家仍在使用滴滴涕控制疟疾，而世界卫生组织目前支持使用滴滴涕的建议是基于这样的假设，即它对人类的健康基本没有不利影响。DDE是DDT的主要降解产物和代谢物。 墨西哥在1999年之前一直使用杀虫剂DDT控制疟疾；那里热带地区的许多人血液中DDT代谢物DDE的水平都升高了。我在墨西哥的项目有两个阶段的实地工作；两个阶段都是基于同一组主题。 我进行了这项研究的第一阶段，在墨西哥塔帕丘拉的781名男性新生儿中，我检查了母亲血清DDE水平与雄激素作用降低的证据之间的关系。所有第一阶段受试者都是在2002-2003年间入选的，应答率为95%。 这项研究的第二阶段于2004财年开始。这项研究跟踪了第一阶段登记的757名妇女和儿童，以确定接触DDT是否与母亲哺乳时间的缩短有关。此外，对后代进行跟踪，以检查早期接触DDT与感染和生长的关系。现已完成跟进工作。计划报告第一阶段和第二阶段调查结果的所有主要论文都已在前几个财年发表。 过去几年的进展： 我们编写了一份关于滴滴涕和儿童胃肠道感染的手稿，将于下一财年完成。

Recent data continue to indicate that use of the insecticide DDT may have adverse effects on human health, but essentially no findings on this topic have been replicated, so the question is still open. Whether DDT has adverse effects is important because DDT is still used for malaria control in about 12 countries, and current recommendations by the World Health Organization that support DDT use are based on the assumption that it has basically no adverse health consequences for humans. DDE is the major degradation product and metabolite of DDT. Mexico used the insecticide DDT for malaria control until 1999; many people there in tropical areas have elevated blood levels of the DDT metabolite, DDE. My project in Mexico had two phases of field work; both were based on the same group of subjects. I conducted phase 1 of this study to examine the relation between maternal serum levels of DDE in relation to evidence of decreased androgen action in 781 newborn males in Tapachula, Mexico. All phase 1 subjects were enrolled in 2002-2003; the response rate was 95%. Phase 2 of this study began in FY 2004. This study followed 757 women and children enrolled in Phase 1, to determine if DDT exposure is related to reduced length of lactation among mothers. In addition, the offspring were followed to examine early-life DDT exposure in relation to infection and growth. Follow-up has been completed. All of the main papers planned to report finding from Phase 1 and Phase 2 have been published in previous fiscal years. Last years progress: We developed a manuscript on DDT and childhood gastrointestinal infections, which will be completed in the coming fiscal year.